This follow-up study to PATH's original coadministration trial demonstrated that measles seroprotection rates were still high one year post-vaccination among infants who originally seroconverted for measles.

Author(s): PATH

Published: 2007

Resource types: PATH resource

Diseases: Japanese encephalitis

Topics: Vaccine safety; Disease/vaccine specific information

Regions: Asia